The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials
Open accessAbstract
BACKGROUND: Contemporary antiretroviral treatment regimens are simpler than in the past, with lower pill burden and once-daily dosing frequency common. We performed a meta-analysis of randomized controlled trials (RCTs) to investigate the impact of pill burden and once-daily vs twice-daily dosing on ART adherence and virological outcomes. METHODS: A literature search of 4 electronic databases through 31 March 2013 was used. RCTs comparing once-daily vs twice-daily ART regimens that also reported on adherence and virological suppression were included. Study design, study population characteristics, intervention, outcome measures, and study quality were extracted. Study quality was rated using the Cochrane risk-of-bias tool. RESULTS: Nineteen studies met our inclusion criteria (N = 6312 adult patients). Higher pill burden was associated with both lower adherence rates (P = .004) and worse virological suppression (P < .0001) in both once-daily and twice-daily subgroups, although the association with adherence in the once-daily subgroup was not statistically significant. The average adherence was modestly higher in once-daily regimens than twice-daily regimens (weighted mean difference = 2.55%; 95% confidence interval [CI], 1.23 to 3.87; P = .0002). Patients on once-daily regimens did not achieve virological suppression more frequently than patients on twice-daily regimens (relative risk [RR] = 1.01; 95% CI, 0.99 to 1.03; P = .50). Both adherence and viral load suppression decreased over time, but adherence decreased less with once-daily dosing than with twice-daily dosing. CONCLUSIONS: Lower pill burden was associated with both better adherence and virological suppression. Adherence, but not virological suppression, was slightly better with once- vs twice-daily regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Estimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Uchino, B. N. (2006) · Journal of Behavioral Medicine · doi:10.1007/s10865-006-9056-5 · Cited by 2,507
Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
Wetterslev, J., Thorlund, K., Brok, J., & Gluud, C. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.03.013 · Cited by 1,881
Brok, J., Thorlund, K., Gluud, C., & Wetterslev, J. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.10.007 · Cited by 1,113
Pop-Eleches, C., Thirumurthy, H., Habyarimana, J. P., Zivin, J. G., Goldstein, M. P., de Walque, D., MacKeen, L., Haberer, J., Kimaiyo, S., Sidle, J., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834380c1 · Cited by 982
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., & Moss, A. (2001) · AIDS · doi:10.1097/00002030-200106150-00015 · Cited by 960
Estimating required information size by quantifying diversity in random-effects model meta-analyses
Wetterslev, J., Thorlund, K., Brok, J., & Gluud, C. (2009) · BMC Medical Research Methodology · doi:10.1186/1471-2288-9-86 · Cited by 938
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
Gallant, J. E., DeJesus, E., Arribas, J. R., Pozniak, A. L., Gazzard, B., Campo, R. E., Lu, B., McColl, D., Chuck, S., Enejosa, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051871 · Cited by 880
Self-citationMills, E. J., Nachega, J. B., Bangsberg, D. R., Singh, S., Rachlis, B., Wu, P., Wilson, K., Buchan, I., Gill, C. J., & Cooper, C. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030438 · Cited by 818
Self-citationFactors Affecting Adherence to Antiretroviral Therapy
Chesney, M. A. (2000) · Clinical Infectious Diseases · doi:10.1086/313849 · Cited by 702
Molina, J.-M., Andrade-Villanueva, J., Echevarria, J., Chetchotisakd, P., Corral, J., David, N., Moyle, G., Mancini, M., Percival, L., Yang, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61081-8 · Cited by 486
Sax, P. E., DeJesus, E., Mills, A., Zolopa, A., Cohen, C., Wohl, D., Gallant, J. E., Liu, H. C., Zhong, L., Yale, K., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60917-9 · Cited by 444
Self-citationAdherence to Nonnucleoside Reverse Transcriptase Inhibitor–Based HIV Therapy and Virologic Outcomes
Nachega, J. B., Hislop, M., Dowdy, D. W., Chaisson, R. E., Regensberg, L., & Maartens, G. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00007 · Cited by 374
Self-citationCohen, C. J., Andrade-Villanueva, J., Clotet, B., Fourie, J., Johnson, M. A., Ruxrungtham, K., Wu, H., Zorrilla, C., Crauwels, H., Rimsky, L. T., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60983-5 · Cited by 374
Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O'Shaughnessy, M. V., & Montaner, J. S. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00008 · Cited by 359
Simoni, J. M., Pearson, C. R., Pantalone, D. W., Marks, G., & Crepaz, N. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000248342.05438.52 · Cited by 343
Garfield, S., Clifford, S., Eliasson, L., Barber, N., & Willson, A. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-149 · Cited by 286
Mills (2010) · Clinical Epidemiology · doi:10.2147/clep.s9242 · Cited by 281
GUIDELINES FOR THE USE OF ANTIRETROVIRAL AGENTS IN HIV-INFECTED ADULTS AND ADOLESCENTS
&NA; (2002) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-200202000-00035 · Cited by 270
Sequential methods for random‐effects meta‐analysis
Higgins, J. P. T., Whitehead, A., & Simmonds, M. (2011) · Statistics in Medicine · doi:10.1002/sim.4088 · Cited by 258
Bärnighausen, T., Chaiyachati, K., Chimbindi, N., Peoples, A., Haberer, J., & Newell, M.-L. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70181-5 · Cited by 246
Better Adherence with Once‐Daily Antiretroviral Regimens: A Meta‐Analysis
Parienti, J., Bangsberg, D. R., Verdon, R., & Gardner, E. M. (2009) · Clinical Infectious Diseases · doi:10.1086/596482 · Cited by 244
Self-citationMartin, A., Bloch, M., Amin, J., Baker, D., Cooper, D. A., Emery, S., & Carr, A. (2009) · Clinical Infectious Diseases · doi:10.1086/644769 · Cited by 222
Eron, J. J., Rockstroh, J. K., Reynes, J., Andrade-Villanueva, J., Ramalho-Madruga, J. V., Bekker, L.-G., Young, B., Katlama, C., Gatell-Artigas, J. M., Arribas, J. R., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70196-7 · Cited by 192
Maggiolo, F. (2010) · Patient Preference and Adherence · doi:10.2147/ppa.s10330 · Cited by 184
Molina, J.-M., LaMarca, A., Andrade-Villanueva, J., Clotet, B., Clumeck, N., Liu, Y.-P., Zhong, L., Margot, N., Cheng, A. K., & Chuck, S. L. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70249-3 · Cited by 171
Reynes, J., Trinh, R. N., Pulido, F., Soto-Malave, R., Gathe, J., Qaqish, R. B., Tian, M., Fredrick, L. M., Podsadecki, T. J., Norton, M., et al. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0275 · Cited by 151
Petersen, M. L., Wang, Y., van der Laan, M. J., Guzman, D., Riley, E. D., & Bangsberg, D. R. (2007) · Clinical Infectious Diseases · doi:10.1086/521250 · Cited by 144
Walensky, R. P., Sax, P. E., Nakamura, Y., Weinstein, M. C., Pei, P. P., Freedberg, K. A., Paltiel, A. D., & Schackman, B. R. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-2-201301150-00002 · Cited by 131
Self-citationMeasuring medication adherence: Are missed doses reported more accurately than perfect adherence?
Wagner, G. J., & Rabkin, J. G. (2000) · AIDS Care · doi:10.1080/09540120050123800 · Cited by 128
Eron, J. J., Feinberg, J., Kessler, H. A., Horowitz, H. W., Witt, M. D., Carpio, F., Wheeler, D. A., Ruane, P. J., Mildvan, D., Yangco, B. G., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/380799 · Cited by 122
Cohen, C. J., Elion, R., Ruane, P. J., Shamblaw, D., DeJesus, E., Rashbaum, B., Chuck, S. L., Yale, K., Liu, H. C., Warren, D. R., et al. (2011) · AIDS · doi:10.1097/qad.0b013e328345766f · Cited by 107
Nachega, J. B., Mugavero, Zeier, Vitória, M., & Gallant, J. E. (2011) · Patient Preference and Adherence · doi:10.2147/ppa.s22771 · Cited by 101
Self-citationMobile phones: exceptional tools for HIV/AIDS, health, and crisis management
Lester, R. T., & Karanja, S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70265-2 · Cited by 96
Hanna, D. B., Hessol, N. A., Golub, E. T., Cocohoba, J. M., Cohen, M. H., Levine, A. M., Wilson, T. E., Young, M., Anastos, K., & Kaplan, R. C. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000082 · Cited by 85
Martínez, E., Arranz, J. A., Podzamczer, D., Loncà, M., Sanz, J., Barragán, P., Ribera, E., Knobel, H., Roca, V., Gutiérrez, F., et al. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181aa12d5 · Cited by 84
Managed Problem Solving for Antiretroviral Therapy Adherence: A Randomized Trial
Gross, R., Bellamy, S. L., Chapman, J., Han, X., O’Duor, J., Palmer, S. C., Houts, P. S., Coyne, J. C., & Strom, B. L. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.2152 · Cited by 83
Self-citationBuscher, A. L., Hartman, C. M., Kallen, M. A., & Giordano, T. P. (2012) · International Journal of STD & AIDS · doi:10.1258/ijsa.2011.011292 · Cited by 78
Self-citationMedication adherence in patients with HIV infection: a comparison of two measurement methods.
Melbourne, K. M., Geletko, S. M., Brown, S. L., Willey-Lessne, C., Chase, S. L., & Fisher, A. (1999) · PubMed · Cited by 75
Molina, J., Podsadecki, T. J., Johnson, M. A., Wilkin, A., Domingo, P., Myers, R. A., Hairrell, J. M., Rode, R. A., King, M. S., & Hanna, G. J. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0107 · Cited by 71
Portsmouth, S., Osorio, J., McCormick, K., Gazzard, B., & Moyle, G. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00287.x · Cited by 67
Clumeck, N., Rieger, A., Bánhegyi, D., Schmidt, W., Hill, A. D., van Delft, Y., Moecklinghoff, C., & Arribas, J. R. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr199 · Cited by 59
Nelson, M. R., Girard, P., DeMasi, R., Chen, L., SMETS, E. F., Sekar, V., & Lavreys, L. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq150 · Cited by 56
A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV
Benson, C. A., van der Horst, C., LaMarca, A., Haas, D. W., McDonald, C., Steinhart, C. R., Rublein, J., Quinn, J., Mondou, E., & Rousseau, F. S. (2004) · AIDS · doi:10.1097/00002030-200411190-00007 · Cited by 55
Sequential meta-analysis: an efficient decision-making tool
van der Tweel, I., & Bollen, C. W. (2010) · Clinical Trials · doi:10.1177/1740774509360994 · Cited by 52
Maitland, D., Jackson, A., Osorio, J., Mandalia, S., Gazzard, B., Moyle, G. J., & for the Epivir‐Ziagen (EZ) Switch Study Team (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00618.x · Cited by 51
Bunupuradah, T., Chetchotisakd, P., Ananworanich, J., Munsakul, W., Jirajariyavej, S., Kantipong, P., Prasithsirikul, W., D, S. S. M., Bowonwatanuwong, C., Klinbuayaem, V., et al. (2012) · Antiviral Therapy · doi:10.3851/imp2443 · Cited by 51
Cooper, V., Horne, R., Gellaitry, G., Vrijens, B., Lange, A.-C., Fisher, M., & White, D. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181ccb762 · Cited by 43
Factors associated with accurate self-reported adherence to HIV antiretrovirals
Kimmerling, M., Wagner, G. J., & Ghosh‐Dastidar, B. (2003) · International Journal of STD & AIDS · doi:10.1258/095646203321264917 · Cited by 36
Zajdenverg, R., Podsadecki, T. J., Badal‐Faesen, S., Andrade-Villanueva, J. F., Gathe, J., Mingrone, H., Fredrick, L. M., Gaultier, I., Woodward, W. C., & Bernstein, B. M. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181cbd21e · Cited by 34
Lamarca, A., Clumeck, N., Plettenberg, A., Domingo, P., Fu, K., Craig, C., Zhao, H. H., Watson, M. E., Gordon, D. N., & Scott, T. R. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000214821.33905.5c · Cited by 29
Campo, R. E., Cohen, C., Grimm, K., Shangguan, T., Maa, J., & Seekins, D. W. (2010) · International Journal of STD & AIDS · doi:10.1258/ijsa.2009.008487 · Cited by 27
Parienti, J., Massari, V., Reliquet, V., Chaillot, F., Moal, G. L., Arvieux, C., Vabret, A., & Verdon, R. (2007) · AIDS · doi:10.1097/qad.0b013e3282eff388 · Cited by 20
Self-citationAndersson, L., Vesterbacka, J., Blaxhult, A., Flamholc, L., Nilsson, S., Ormaasen, V., Sönnerborg, A. B., & Gisslén, M. (2013) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2012.756985 · Cited by 14
Cited by
Shubber, Z., Mills, E. J., Nachega, J. B., Vreeman, R., Freitas, M., Bock, P., Nsanzimana, S., Penazzato, M., Appolo, T., Doherty, M., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002183 · Cited by 526
Self-citationUthman, O. A., Magidson, J. F., Safren, S. A., & Nachega, J. B. (2014) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0220-1 · Cited by 466
Self-citationTseng, A., Seet, J., & Phillips, E. J. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12403 · Cited by 256
Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy
Kirtane, A. R., Abouzid, O., Minahan, D., Bensel, T., Hill, A. L., Selinger, C., Bershteyn, A., Craig, M., Mo, S. S., Mazdiyasni, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02294-6 · Cited by 227
Nachega, J. B., Uthman, O. A., Peltzer, K., Richardson, L. A., Mills, E. J., Amekudzi, K., & Ouédraogo, A. (2015) · Bulletin of the World Health Organization · doi:10.2471/blt.14.138149 · Cited by 125
Self-citation
Metadata
- Authors
- Nachega, J. B., Parienti, J.-J., Uthman, O. A., Gross, R., Dowdy, D. W., Sax, P. E., Gallant, J. E., Mugavero, M. J., Mills, E. J., & Giordano, T. P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-22
- Volume
- 58
- Issue
- 9
- Pages
- 1297-1307
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2121737909
- Cited by
- 357
- References
- 61
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.